Latest News - Abbott Laboratories
Top Corporates Hub
Abbott Laboratories
Is Abbott Laboratories (ABT) Appealing After Recent Share Price Pullback?
11.04.2026 00:24
If you are wondering whether Abbott Laboratories at around US$100 a share still reflects its underlying worth, you are not alone. This article is built to help you frame that question clearly. The stock has recently pulled back, with a 2.5% decline over the last 7 days and a 9.0% decline over the last 30 days, contributing to a 19.5% decline over the last year. Recent news coverage has focused on Abbott Laboratories as a large, diversified healthcare name that often features in discussions...
Market Chatter: Abbott Ordered to Pay $53 Million in Damages to Chicago Families Over Infant Formula
10.04.2026 07:39
Abbott Laboratories (ABT) has been ordered by a jury in Chicago to pay $53 million in compensatory d
Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says
10.04.2026 02:25
By Diana Novak Jones CHICAGO, April 9 (Reuters) - A jury in Chicago on Thursday said Abbott Laboratories must pay $53 million in compensatory damages to a group of families that had accused the
Abbott (ABT) Reports Next Week: Wall Street Expects Earnings Growth
09.04.2026 14:00
Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
09.04.2026 13:00
Today, Abbott (NYSE: ABT), a global leader in chronic disease prevention, treatment and care, is releasing new survey findings highlighting a growing tension: 74% of U.S. adults believe most chronic diseases, such as diabetes or cardiovascular disease, are preventable, but only 1 in 4 feel very confident in knowing how to care for their health.
Abbott Laboratories: A Dividend Aristocrat With A Compelling Valuation And Return Potential
09.04.2026 09:00
Abbott Laboratories' acquisition of Exact Sciences adds a solid piece to a company with a long proven track record. Learn why ABT stock is a buy.
Tired of AI and Oil? Buy the Robot.
08.04.2026 13:31
Intuitive Surgical (ISRG) is currently hovering around the $450 mark, a level that has historically acted as a psychological and technical floor. For an investor, the question isn't just "is it cheap?" (it almost never is), but "is the premium still justified?”.
Barclays Maintains Overweight on Abbott Laboratories, Raises Price Target to $144
08.04.2026 09:58
Barclays analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $142 to $144.
Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness
08.04.2026 03:12
Abbott Laboratories stock snapshot Abbott Laboratories (ABT) has drawn investor attention after a weak share price patch, with the stock down about 7% over the past month and 20% over the past 3 months. At a last close of US$101.83 and a market value near US$178.2b, Abbott sits on annual revenue of about US$44.3b and net income of roughly US$6.5b across its diversified healthcare segments. See our latest analysis for Abbott Laboratories. Recent trading shows momentum fading, with the 30 day...
Abbott’s Whoop Investment Puts Digital Health Wearables On Shareholders’ Radar
02.04.2026 02:11
Abbott Laboratories (NYSE:ABT) has invested in Whoop's US$575m Series G funding round as a strategic participant. The deal links Abbott's medical device and diagnostics expertise with Whoop's health wearable and insights platform focused on consumer users. The investment highlights Abbott's interest in digital health wearables and consumer facing health data solutions. For a company best known for diagnostics, medical devices and nutrition products, Abbott's move into a US$575m funding...
Whoop concludes $575m fundraise, adding Abbott as strategic investor
01.04.2026 10:47
Whoop noted that alongside Abbott, the company's share a mutual interest in "empowering people to take control of their health".
Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock
01.04.2026 10:41
Discover Abbott Laboratories, a top dividend stock with a reliable 2.4% yield, strong growth, and a robust financial foundation for sustainable passive income.
Will Integrating Precision Oncology Tests into OncoEMR Change Abbott Laboratories' (ABT) Narrative?
30.03.2026 18:07
Abbott and Flatiron Health recently integrated Abbott's Precision Oncology portfolio into Flatiron's OncoEMR platform, allowing more than 1,600 community cancer centers and 4,700 providers to order and receive results for tests such as Oncotype DX Breast Recurrence Score®, OncoExTra®, Oncodetect®, and Riskguard® directly within their existing clinical workflows. This unified digital access to multiple cancer diagnostics in routine oncology practice could meaningfully enhance test adoption,...
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
30.03.2026 13:00
Abbott (NYSE: ABT), the global healthcare company, and Flatiron Health, a leading healthtech company advancing point-of-care solutions in oncology, today announced the integration of Abbott's comprehensive Precision Oncology portfolio into OncoEMR®, Flatiron's cloud-based Electronic Medical Record (EMR) platform.
Abbott And Flatiron Health Announce Integration Of Abbott's Comprehensive Precision Oncology Portfolio Into OncoEMR, Flatiron's Cloud-Based EMR Platform
30.03.2026 09:06
Broadens access to Abbott's Precision Oncology tests across more than 1,600 community cancer care centers and 4,700 providers in Flatiron's North America network, helping accelerate informed treatment decisionsAllows
Clinical Nutrition for Diabetes Care Market Report 2026-2030 Featuring Profiles of Key Players - Pfizer, Bayer, Sanofi-Aventis, Abbott Labs, Roche and More
27.03.2026 14:36
The rise of diabetes, demand for specialized nutrition, digital monitoring tools, and home-based management are key trends driving market growth Clinical Nutrition for Diabetes Care Market Clinical Nutrition for Diabetes Care Market Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Clinical Nutrition for Diabetes Care Market Report 2026" has been added to ResearchAndMarkets.com's offering. The clinical nutrition for diabetes care market has experienced robust growth recently, expanding from $3.17
Philips wins FDA clearance for imaging device developed with Edwards
27.03.2026 10:16
The system uses AI to optimize the placement of Edwards’ mitral valve repair device.
Abbott Earnings Preview: What to Expect
25.03.2026 13:06
Abbott is expected to announce its first-quarter results soon, and analysts are projecting single-digit EPS growth.
Abbott Laboratories (NYSE:ABT) Passes the 'Caviar Cruise' Quality Investing Screen
25.03.2026 10:11
Abbott Laboratories exemplifies quality investing with strong financials, high profitability, and durable competitive advantages in healthcare.
The Zacks Analyst Blog Highlights Eli Lilly, RTX, Abbott Laboratories, Ohio Valley Banc and Rave Restaurant
24.03.2026 13:45
Eli Lilly, RTX, Abbott, Ohio Valley Banc, and Rave Restaurant make Zacks' daily analyst blog with fresh insights on growth and market trends.